These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31715060)

  • 1. In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response.
    Calvani J; Terada M; Lesaffre C; Eloudzeri M; Lamarthée B; Burger C; Tinel C; Anglicheau D; Vermorel A; Couzi L; Loupy A; Duong Van Huyen JP; Bruneval P; Rabant M
    Am J Transplant; 2020 Apr; 20(4):942-953. PubMed ID: 31715060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response].
    Rabant M; Calvani J; Terada M; Lesaffre C; Duong Van Huyen JP; Bruneval P
    Nephrol Ther; 2019 Apr; 15 Suppl 1():S43-S52. PubMed ID: 30981395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Shah Y; Yang H; Mueller FB; Li C; Gul Rahim SE; Varma E; Salinas T; Dadhania DM; Salvatore SP; Seshan SV; Sharma VK; Elemento O; Suthanthiran M; Muthukumar T
    Kidney Int; 2024 Feb; 105(2):347-363. PubMed ID: 38040290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.
    Parkes MD; Halloran PF; Hidalgo LG
    Am J Transplant; 2018 Jan; 18(1):63-73. PubMed ID: 28654216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.
    Halloran PF; Venner JM; Famulski KS
    Am J Transplant; 2017 Jul; 17(7):1754-1769. PubMed ID: 28101959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Distribution of Macrophage Subtypes Among Rejection Subtypes in Renal Transplant Biopsies by Dual Immunohistochemistry.
    Hurdogan O; Karakus F; Dirim AB; Aksu B; Saygili S; Turkmen A; Yilmaz A; Canpolat N; Solakoglu S; Kilicaslan I; Ozluk Y
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):224-231. PubMed ID: 36812388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies.
    Gauthier PT; Mackova M; Hirji A; Weinkauf J; Timofte IL; Snell GI; Westall GP; Havlin J; Lischke R; Zajacová A; Simonek J; Hachem R; Kreisel D; Levine D; Kubisa B; Piotrowska M; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Halloran K; Halloran PF
    Am J Transplant; 2023 Dec; 23(12):1922-1938. PubMed ID: 37295720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.
    Buxeda A; Llinàs-Mallol L; Gimeno J; Redondo-Pachón D; Arias-Cabrales C; Burballa C; Puche A; López-Botet M; Yélamos J; Vilches C; Naesens M; Pérez-Sáez MJ; Pascual J; Crespo M
    Am J Transplant; 2023 Apr; 23(4):464-474. PubMed ID: 36710135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56
    Bailly E; Macedo C; Ossart J; Louis K; Gu X; Ramaswami B; Bentlejewski C; Zeevi A; Randhawa P; Lefaucheur C; Metes D
    Kidney Int; 2023 Oct; 104(4):707-723. PubMed ID: 37220805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: The transcripts associated with organ allograft rejection.
    Halloran PF; Venner JM; Madill-Thomsen KS; Einecke G; Parkes MD; Hidalgo LG; Famulski KS
    Am J Transplant; 2018 Apr; 18(4):785-795. PubMed ID: 29178397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies.
    Egelkamp J; Chichelnitskiy E; Kühne JF; Wandrer F; Daemen K; Keil J; Bräsen JH; Schmitz J; Bellmàs-Sanz R; Iordanidis S; Katsirntaki K; Hake K; Akhdar A; Neudörfl C; Haller H; Blume C; Falk CS
    Am J Transplant; 2019 Oct; 19(10):2692-2704. PubMed ID: 31062482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal urinary cell gene signature of acute rejection in kidney allografts.
    Salinas T; Li C; Snopkowski C; Sharma VK; Dadhania DM; Suhre K; Muthukumar T; Suthanthiran M
    J Immunol Methods; 2024 Sep; 532():113714. PubMed ID: 38936464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
    Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and urinary levels of endothelial protein C receptor correlate with acute renal allograft rejection.
    Lattenist L; Kers J; Claessen N; ten Berge IJ; Bemelman FJ; Florquin S; Roelofs JJ
    PLoS One; 2013; 8(5):e64994. PubMed ID: 23717683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
    Haas M
    Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.
    Goutaudier V; Perrochia H; Mucha S; Bonnet M; Delmas S; Garo F; Garrigue V; Lepreux S; Pernin V; Serre JE; Szwarc I; Merville P; Ramounau-Pigot A; René C; Visentin J; Morgan BP; Frémeaux-Bacchi V; Mourad G; Couzi L; Le Quintrec M
    Front Immunol; 2019; 10():235. PubMed ID: 30906289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.